发明名称 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
摘要 The invention provides chimeric antigen receptors (CARs) comprising an antigen binding domain of a KDR-1121 or DC101 antibody, an extracellular hinge domain, a T cell receptor transmembrane domain, and an intracellular domain T cell receptor signaling domain. Nucleic acids, recombinant expression vectors, host cells, populations of cells, antibodies, or antigen binding portions thereof, and pharmaceutical compositions relating to the CARs are disclosed. Methods of detecting the presence of cancer in a host and methods of treating or preventing cancer in a host are also disclosed.
申请公布号 US8822196(B2) 申请公布日期 2014.09.02
申请号 US201313875560 申请日期 2013.05.02
申请人 The United States of America, as represented by the Secretary, Department of Health and Human Services 发明人 Rosenberg Steven A.;Chinnasamy Dhanalakshmi
分类号 C12N15/62;C07K14/705;C07K16/28;C12N15/63;C12N15/79 主分类号 C12N15/62
代理机构 Leydig, Voit & Mayer, Ltd. 代理人 Leydig, Voit & Mayer, Ltd.
主权项 1. A nucleic acid comprising a nucleotide sequence encoding a chimeric antigen receptor (CAR) comprising (a) an antigen binding domain of a KDR-1121 or DC101 antibody, wherein the antigen binding domain comprises an amino acid sequence comprising SEQ ID NO: 1 or 2; (b) an amino acid sequence comprising SEQ ID NO: 3, 4, or 7; and (c) an amino acid sequence comprising SEQ ID NO: 5, 6, 8, or 9.
地址 Washington DC US